MetLife 2004 Annual Report Download - page 78

METLIFE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
($1,662 million) over the contract price of the stock issued to the purchase contract holders ($1,006 million) was $656 million, which was recorded as a
direct reduction to retained earnings.
Due to the dissolution of the Trust in 2003, there was no interest expense on capital securities for the year ended December 31, 2004. Interest
expense on the capital securities is included in other expenses and was $10 million and $81 million for the years ended December 31, 2003 and 2002,
respectively.
GenAmerica Capital I. In June 1997, GenAmerica Corporation (‘‘GenAmerica’’) issued $125 million of 8.525% capital securities through a wholly-
owned subsidiary trust, GenAmerica Capital I. GenAmerica has fully and unconditionally guaranteed, on a subordinated basis, the obligation of the trust
under the capital securities and is obligated to mandatorily redeem the securities on June 30, 2027. GenAmerica may prepay the securities any time after
June 30, 2007. Capital securities outstanding were $119 million, net of unamortized discounts of $6 million, at both December 31, 2004 and 2003.
Interest expense on these instruments is included in other expenses and was $11 million for each of the years ended December 31, 2004, 2003 and
2002.
RGA Capital Trust I. In December 2001, RGA, through its wholly-owned trust, RGA Capital Trust I (the ‘‘Trust’’), issued 4,500,000 Preferred Income
Equity Redeemable Securities (‘‘PIERS’’) Units. Each PIERS unit consists of (i) a preferred security issued by the Trust, having a stated liquidation amount
of $50 per unit, representing an undivided beneficial ownership interest in the assets of the Trust, which consist solely of junior subordinated debentures
issued by RGA which have a principal amount at maturity of $50 and a stated maturity of March 18, 2051, and (ii) a warrant to purchase, at any time prior
to December 15, 2050, 1.2508 shares of RGA stock at an exercise price of $50. The fair market value of the warrant on the issuance date was $14.87
and is detachable from the preferred security. RGA fully and unconditionally guarantees, on a subordinated basis, the obligations of the Trust under the
preferred securities. The preferred securities and subordinated debentures were issued at a discount (original issue discount) to the face or liquidation
value of $14.87 per security. The securities will accrete to their $50 face/liquidation value over the life of the security on a level yield basis. The weighted
average effective interest rate on the preferred securities and the subordinated debentures is 8.25% per annum. Capital securities outstanding were
$159 million and $158 million for the years ended December 31, 2004 and 2003, respectively, net of unamortized discount of $67 million, at both
December 31, 2004 and 2003.
9. Income Taxes
The provision for income taxes for continuing operations was as follows:
Years Ended December 31,
2004 2003 2002
(Dollars in millions)
Current:
Federal ************************************************************************************ $ 733 $349 $ 797
State and local ***************************************************************************** 51 22 (17)
Foreign ************************************************************************************ 154 47 31
938 418 811
Deferred:
Federal ************************************************************************************ 191 227 (338)
State and local ***************************************************************************** 627 16
Foreign ************************************************************************************ (64) (12) 1
133 242 (321)
Provision for income taxes ********************************************************************** $1,071 $660 $ 490
Reconciliations of the income tax provision at the U.S. statutory rate to the provision for income taxes as reported for continuing operations were as
follows:
Years Ended December 31,
2004 2003 2002
(Dollars in millions)
Tax provision at U.S. statutory rate ************************************************************* $1,323 $ 895 $561
Tax effect of:
Tax exempt investment income ************************************************************** (131) (118) (88)
State and local income taxes *************************************************************** 37 44 20
Prior year taxes *************************************************************************** (105) (26) (7)
Foreign operations net of foreign income taxes************************************************* (36) (81) (1)
Other, net******************************************************************************** (17) (54) 5
Provision for income taxes ******************************************************************** $1,071 $ 660 $490
The Company is under continuous examination by the Internal Revenue Service (‘‘IRS’’) and other tax authorities in jurisdictions in which the
Company has significant business operations. The income tax years under examination vary by jurisdiction. In 2004 the Company recorded an
adjustment of $91 million for the settlement of all federal income tax issues relating to the IRS’s audit of the Company’s tax returns for the years 1997-
1999. Such settlement is reflected in the current year tax expense as an adjustment to prior year taxes. The Company also received $22 million in interest
on such settlement and incurred an $8 million tax expense on such settlement for a total impact to net income of $105 million. The current IRS
examination covers the years 2000-2002. The Company regularly assesses the likelihood of additional assessments in each taxing jurisdiction resulting
from current and subsequent years’ examinations. Liabilities for income taxes have been established for future income tax assessments when it is
probable there will be future assessments and the amount thereof can be reasonably estimated. Once established, liabilities for uncertain tax positions
MetLife, Inc. F-35